Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients

. 2022 Mar 01 ; 106 (3) : e183-e184.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid34856599
Odkazy

PubMed 34856599
PubMed Central PMC8862668
DOI 10.1097/tp.0000000000004021
PII: 00007890-202203000-00039
Knihovny.cz E-zdroje

Zobrazit více v PubMed

Peled Y, Ram E, Lavee J, et al. . BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response. J Heart Lung Transplant. 2021;40:759–762. PubMed PMC

Havlin J, Svorcova M, Dvorackova E, et al. . Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients. J Heart Lung Transplant. 2021;40:754–758. PubMed PMC

Peled Y, Ram E, Lavee J, et al. . Third dose of the BNT162b2 vaccine in heart transplant recipients: immunogenicity and clinical experience. J Hear Lung Transplant. 2022;41:148–157. PubMed PMC

Kamar N, Abravanel F, Marion O, et al. . Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. PubMed PMC

Kantauskaite M, Müller L, Kolb T, et al. . Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. Am J Transplant. 2022;22:634–639. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...